Loading ...

Stock Quote sctpf

sctpf Stock Price Today

sctpf Price History

sctpf Stock Price History

sctpf History

Last Price sctpf

Close Price sctpf

Day Change sctpf

After Hours Quote sctpf

Open Price sctpf

Day Range sctpf

Year Range sctpf

Projected Yield sctpf

Market Cap sctpf

Stock Volume sctpf

Average Volume sctpf

Forward Price sctpf

PE for sctpf

PB for sctpf

PS for sctpf

PCF for sctpf

price earnings ratio sctpf

price to book ratio sctpf

price to sales ratio sctpf

price to cash flow ratio sctpf

Stock Quote Trillium Therapeutics Inc

Trillium Therapeutics Inc Stock Price today

Trillium Therapeutics Inc Price history

Trillium Therapeutics Inc Stock Price history

Trillium Therapeutics Inc history

Last Price Trillium Therapeutics Inc

Close Price Trillium Therapeutics Inc

Day Change Trillium Therapeutics Inc

After Hours Quote for Trillium Therapeutics Inc

Open Price Trillium Therapeutics Inc

Day Range Trillium Therapeutics Inc

Year Range Trillium Therapeutics Inc

Projected Yield Trillium Therapeutics Inc

Market Cap Trillium Therapeutics Inc

Stock Volume Trillium Therapeutics Inc

Average Volume Trillium Therapeutics Inc

Forward Price Trillium Therapeutics Inc

pe Trillium Therapeutics Inc

pb Trillium Therapeutics Inc

ps Trillium Therapeutics Inc

pcf Trillium Therapeutics Inc

price earnings ratio Trillium Therapeutics Inc

price to book ratio Trillium Therapeutics Inc

price to sales ratio Trillium Therapeutics Inc

price to cash flow ratio Trillium Therapeutics Inc

What Does This Company Do?
Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immunoregulatory pathways that tumor cells exploit to evade the host immune system.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Employees
15
Stock Style
Small Value

Key Stats  SCTPF More...

Key Stats SCTPF

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  sctpf - Trillium Therapeutics Inc More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports sctpf - Trillium Therapeutics IncMore...

Click above to view more mutual fund data and stats for sctpf - Trillium Therapeutics Inc.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings
Stock Price Quote: sctpf Trillium Therapeutics Inc - PINX - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: sctpf - Trillium Therapeutics Inc  |  Next: altri - Trilogiq SA